AVP and metabolic dysfunction-associated steatotic liver disease: Furthermore, as the risk of developing NAFLD is suggested to differ by ethnicity [16, 17], this study aims at for the first time investigating copeptin concentration as well as links between fatty liver disease and plasma copeptin concentrations in different ethnic groups.